Antral gastrin cell hyperfunction and Helicobacter pylori infection

Alimentary Pharmacology and Therapeutics

Volumn 10, Issue 4, 1996, Pages 607-615

  Annibale, B ^b   Rindi, G ^a   D'Ambra, G ^b   Marignani, M ^b   Solcia, E ^a   Bordi, C ^c   Delle Fave, G ^b,d  

^a UNIVERSITY OF PAVIA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF PARMA   (Italy)

^d POLICLINICO UMBERTO I   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BISMUTH CITRATE; GASTRIN; METRONIDAZOLE; OMEPRAZOLE; PEPSINOGEN;

ADULT; ARTICLE; BACTERIAL INFECTION; ENDOSCOPY; FEMALE; GASTRIN CELL; GASTRODUODENAL ULCER; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STOMACH ACID SECRETION; ZOLLINGER ELLISON SYNDROME;

EID: 0030035409     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1996.31173000.x     Document Type: Article

References (46)

1. Graham DY. Treatment of peptic ulcer caused by Helicobacter pylori. N Engl J Med 1993; 328: 349-50.
2. Peterson WL. Helicobacter pylori and peptic ulcer disease. N Engl J Med 1991; 324: 1043-47.
3. Friesen SR, Tomita T. Pseudo-Zollinger-Ellison syndrome. Hypergastrinemia, hyperchlorhydria without tumor. Ann Surg 1981; 194: 481-93.
4. Taylor IL, Calam J, Rotter JL, et al. Family studies of hypergastrinemic, hyperpepsinogenemic I duodenal ulcer. Ann Intern Med 1981; 95: 421-5.
5. Delle Fave G, Annibale B, Puoti M, et al. Medical treatment of antralgastrin cell hyperfunction: role of non-antisecretory therapy. Digestion 1990; 46: 65-71.
6. Annibale B, de Magistris L, Corleto V, et al. Zollinger-Ellison syndrome and antral G-cell hyperfunction in patients with resistant duodenal ulcer disease. Aliment Pharmacol Ther 1994; 8: 87-93.
7. Walsh JH, Nair PK, Kleibeuker J, et al. Pathological acid secretion not due to gastrinoma. Scand J Gastroenterol 1983; 18 (Suppl. 28): 45-58.
8. Polak JM, Stagg B, Pearse AGE. Two types of Zollinger-Ellison syndrome, Immunofluorescent, cytochemical and ultrastructural studies of the antral and pancreatic gastrin cells in different clinical states. Gut 1972; 13: 501-2.
9. Wolfe MM, Jensen RT. Zollinger-Elison syndrome. N Engl J Med 1987; 317: 1200-9.
10. Jensen RT, Gardner JD. Gastrinoma. In: Go VLW, Di Magno EP, Gardner JD, Lehenthal E, Rebler HA, eds. The Exocrine Pancreas: Biology, Pathobiology and Disease, Volume 1, 1st edn. New York: Raven Press, 1986: 727-44.
11. Arnold R, Eissele R, Frank M, Koop H. Regulation of G cell proliferation. In: Walsh JH, ed. Gastrin. New York: Raven Press, 1993: 91-101.
12. Rindi G, Annibale B, Corleto V, et al. Helicobacter pylori infection in children with antral gastrin cell hyperplasia. J Pediatr Gastroenterol Nutr 1993; 18: 152-8.
13. Annibale B, Bonamico M, Rindi G, et al. Antral gastrin cell hyperfunction in children. Gastroenterology 1991; 101: 1547-51.
14. Smith JT, Pounder RE, Nwokolo CU, et al. Inappropiate hypergastrinemia in asymptomatic healthy subjects infected with Helicobacter pylori. Gut 1990; 31: 522-5.
15. Levi S, Beardshall K, Swift I, et al. Antral Helicobacter pylori hypergastrinemia and duodenal ulcer: effect of eradicating the organism. BMJ 1989; 299: 1504-5.
16. Levi S, Beardshall K, Haddad G, et al. Campylobacter pylori and duodenal ulcers: the gastrin link. Lancet 1989; i: 1167-8.
17. Goldschmyiedt M, Barnett CC, Schwarz BE, et al. Effect of age on gastric acid secretion and serum gastrin concentrations in healthy men and women. Gastroenterology 1991; 101: 977-90.
18. Moss SF, Legon S, Bishop AE, Polak JM, Calam J. Effect of Helicobacter pylori on gastric somatostatin in duodenal ulcer. Lancet 1992; 340: 930-2.
19. Queiroz DM, Moura SB, Mendes EN, et al. Effect of Helicobacter pylori on G cell and D cell density in children. Lancet 1994; 343: 1191-3.
20. Odum L, Petersen HD, Andersen IB, Hansen BF, Rehfeld JF. Gastrin and somatostatin in Helicobacter pylori infected antral mucosa. Gut 1994; 35: 615-8.
21. Graham DY, Lew GM, Lechago J. Antral G-cell and D-cell numbers in Helicobacter pylori infection: effect of H. pylori eradication. Gastroenterology 1993; 104: 1655-60.
22. 2 antagonists. J Clin Gastroenterol 1991; 13: 284-90.
23. Delle Fave G, Kohn A, de Magistris L, Mancuso M, Sparvoli C. Effect of bombesin-stimulated gastrin on gastric secretion in man. Life Sci 1980; 27: 993-9.
24. Delle Fave G, Kohn A, de Magistris L, et al. Effects of bombesin on gastrin and gastric acid secretion in patients with duodenal ulcer. Gut 1983; 24: 231-5.
25. de Magistris L, Rehfeld JF. A simple enzymatic procedure for radioimmunochemical quantification of the large molecular forms of gastrin and cholecystokinin. Ann Biochem 1980; 102: 126-33.
26. Delle Fave G, Annibale B, de Magistris L. Gastrin pathophysiology: antisecretory drugs. Ital J Gastroenterol 1990; 22 (Suppl. 2): 32-5.
27. Delle Fave G, Annibale B, de Magistris L, et al. Bombesin effects on human GI functions. Peptides 1985; 6 (Suppl. 3): 113-6.
28. Price AB. The Sydney system: histological division. J Gastroenterol Hepatol 1991; 6: 209-22.
29. Bordi C, Azzoni C, Pilato FP, et al. Morphometry of gastric endocrine cells in hypergastrinemic patients treated with somatostatin analogue octreotide. Regul Pept 1993; 47: 307-18.
30. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase technique. J Histochem Cytochem 1981; 29: 577-80.
31. Cooper RG, Dockray GJ, Calam J, Walker R. Acid and gastrin responses during intragastric titration in normal subjects and duodenal ulcer patients with G-cell hyperfunction. Gut 1985; 26: 232-6.
32. D'Adda T, Pilato FP, Lazzaroni M, et al. Ultrastructural morphometry of gastric endocrine cells before and after omeprazole. A study in oxyntic mucosa of duodenal ulcer patients. Gastroenterology 1991; 100: 1563-70.
33. Karnes WE, Ohning GV, Sytnik B, Kim SWR, Walsh JH. Elevation of meal stimulated gastrin release in subjects with Helicobacter pylori infection: reversal by low intragastric pH. Rev Infect Dis 1991; 13 (Suppl. 8): S665-70.
34. Kang JY, Wee A. Helicobacter pylori and gastric acid output in peptic ulcer disease. Dig Dis Sci 1991; 36: 5-9.
35. McColl KEL, Fullarton GM, Chittajala R, et al. Plasma gastrin, daytime intragastric pH, and nocturnal acid output before and at 1 and 7 months after eradication of Helicobacter pylori in duodenal ulcer subjects. Scand J Gastroenterol 1991; 26: 339-46.
36. Brady CE III, Hadfield TL, Hyatt JR, Utts S. Acid secretion and scrum gastrin levels in individuals with Campylobacter pylori. Gastroenterology 1988; 94: 932-7.
37. Kang JY, Wee A. Helicobacter pylori and gastric acid output in peptic ulcer disease. Dig Dis Sci 1991; 36: 5-9.
38. Chittajallu RS, Howie CA, McColl KEL. Effect of Helicobacter pylori on parietal cell sensitivity to pentagastrin in duodenal ulcer subjects. Scand J Gastroenterol 1992; 27: 857-62.
39. Crabtree JE, Shallcross I, Wyatt JL, Heatley RV. Tumour necrosis factor alpha secretion by Helicobacter pylori colonized gastric mucosa. Gut 1991; 32: 1473-7.
40. Godley JM, Brand SJ. Regulation of the gastrin promoter by epidermal growth factor and neuropeptides. Proc Natl Acad Sci USA 1989; 86: 3036-40.
41. Teichmann RK, Pratschke E, Grab J, Hammer C, Brendel W. Gastrin release by interleukin-2 and gamma-interferon in vitro. Can J Physiol Pharmacol 1986; 64 (Suppl.): 62.
42. Nakanishi T, Shiniomura Y, Kanayama S, Matsuzawa Y. Eradication of Helicobacter pylori normalizes serum gastrin concentration and antral cell number in a patient with primary gastrin cell hyperplasia. Am J Gastroenterol 1993; 88: 440-2.
43. Metz D, Weber C, Orbuch M, et al. Helicobacter pylori infection. A reversible cause of hypergastrinemia and hyperchloridria which mimic Zollinger-Ellison syndrome. Dig Dis Sci 1995; 40: 153-9.
44. Oderda G, Fiocca R, Villani L, et al. Gastrin cell hyperplasia in childhood Helicobacter pylori gastritis. Eur J Gastroenterol Hepatol 1993; 5: 13-6.
45. Sankey EA, Helliwell PA, Dhillon AP. Immunostaining of antral gastrin cells is quantitatively increased in Helicobacter pylori gastritis. Histopathology 1990; 16: 155-5.
46. Courillon-Mallet A, Launay JM, Roucayrol AM, et al. Helicobacter pylori infection: Physiopathologic implication of N alfamethyl histamine. Gastroenterology 1995; 108: 959-66.